.

New Deal

New Deal

Announced

17 Oct 2017

Completed

7 May 2018

IMPAX LABORATORIES INC / AMNEAL PHARMACEUTICALS LLC / Merger / Public / £4819m

Financials

Edit Data

Transaction Value-

Consideration Type-

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Impax Laboratories

bidder

Amneal Pharmaceuticals

Sources

Edit

Tags

Edit

pharmaceuticals

Pharmaceuticals

Public

Merger

Completed

Friendly

Single Bidder

United States

Synopsis

Edit

Merger of equals between Amneal Pharmaceuticals and Impax Laboratories, a developer, manufacturer, and marketer of bioequivalent pharmaceutical products._x000D_ _x000D_

Service Providers (2)

Dealmakers

financial advisors

Houlihan Lokey

legal advisors

Latham & Watkins

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US